Filing Details

Accession Number:
0001209191-23-059133
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-19 16:15:25
Reporting Period:
2023-12-18
Accepted Time:
2023-12-19 16:15:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1659323 Iterum Therapeutics Plc ITRM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553593 W. Michael Dunne C/O Iterum Therapeutics Plc
Fitzwilliam Court, Fl. 1, Leeson Close
Dublin 2 L2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2023-12-18 10,000 $1.84 88,754 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.795 to $1.85. The Reporting Person undertakes to provide upon request of the SEC staff, the Issuer, or any shareholder of the Issuer, full information requiring the number of securities purchased at each separate price within the range set forth in this footnote.